Dynavax Technologies Corp (LTS:0IDA)
$ 12.9401 0 (0%) Market Cap: 1.71 Bil Enterprise Value: 1.20 Bil PE Ratio: 100.00 PB Ratio: 2.51 GF Score: 67/100

Q1 2024 Dynavax Technologies Corp Earnings Call Transcript

May 08, 2024 / 08:30PM GMT
Release Date Price: $11.71 (-0.83%)
Operator

Good day, ladies and gentlemen, and welcome to the Dynavax Technologies first quarter 2024 financial results conference call. As a reminder, this call is being recorded. At the end of the company's prepared remarks, we'll open the call for questions and provide specific participation instructions at that time.

I would now like to turn the call over to Paul Cox, Vice President, Investor Relations and Corporate Communications. Please begin, sir.

Paul Cox
Dynavax Technologies Corporation - VP, IR and Corporate Communications

Thank you for participating in today's call. Joining me from Dynavax are Ryan Spencer, Chief Executive Officer; Donn Casale, Chief Commercial Officer; Rob Janssen, Chief Medical Office; and our Interim Head of Finance, Rita O'Connor.

Earlier today, Dynavax released financial results for the first quarter ended March 31, 2024. Copies of the press release and the supplementary slide presentation are available on Dynavax's website.

Before we begin, I advise you that we will be making forward-looking statements today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot